Victoria Hiscock Discusses Vitamin a As a Skincare Ingredient

Total Page:16

File Type:pdf, Size:1020Kb

Victoria Hiscock Discusses Vitamin a As a Skincare Ingredient SKIN/DERMATOLOGY VITAMIN A www.aestheticmed.co.uk “A” STA R Victoria Hiscock discusses vitamin A as a skincare ingredient ithout question, the greatest boon to anti- BIO-AVAILABILITY OF RETINOIDS ageing treatments was the introduction of The amount of biological activity will differ with each substrate retinoic acid by Albert M Kligman, MD, PhD in of vitamin A. Retinoic acid is the only form of retinol the body 1986. Since then, the world of vitamin A has can use, therefore, the body uses specialised enzymes in exploded and many new compounds have been the skin cells to convert vitamin A into retinoic acid. Not all Wdeveloped to treat a host of skin conditions. forms of vitamin A are created equally. Some are more easily There are many different types of vitamin A which vary in converted to retinoic acid than others. A typical conversion strength and action. These can be seen in the table below. pathway looks like this: VITAMIN A SUBSTRATES – By strength Retinyl palmitate <=> Retinol <=> Retinaldehyde => Retinoic acid Retinoic Acid Tretinoin It takes two and three metabolic steps, correspondingly, (All-Trans-Retnoic-Acid/ (prescription only) to convert retinol and retinyl palmitate to retinoic acid. ATRA) The overall rate of conversion of retinol to retinoic Retinyl Retinoate Chemically joined Retinoic acid is low and that of retinyl palmitate is lower still. Acid and Retinol Molecules Therefore, a relatively large amount of retinol and Retinal / Retinaldehyde Can convert to Retinoic Acid even larger amount of retinyl palmitate needs to be or Retinol delivered into a cell to boost retinoic acid levels and Retinol Entire Vitamin A Molecule produce clinically meaningful effects. Among retinoid precursors, retinaldehyde Retinyl Palmitate Ester of Retinol & Palmitic (retinal) is the nearest (on the metabolic pathway) Acid (a fatty acid) to retinoic acid and is likely to match its benefits Retinal Acetate Synthetic ester of Retinol more closely. & Acetic Acid (organic Although no one has clinically demonstrated compound) the conversion rate of retinol to retinoic acid, (as Retinyl esters Storage form of a Vitamin it is subjective), it is believed to be roughly about one-tenth the strength of Tretinoin. WHAT IS RETINOL? What is retinol? That is a questions that often gets asked. BIO-CHEMICAL PATHWAY OF RETINOIDS Retinol is a form of vitamin A that is used in skincare to There are several kinds of retinoid receptors, each return the skin to more youthful state by stimulating the affecting different cellular processes. fibroblast cells responsible for collagen, elastin, hydration First, retinol is oxidised to form retinal. Then retinal is and cellular turnover. oxidised to generate retinoic acid, which binds to retinoid Although retinol belongs to the family of chemical compounds receptors of skin cells—a step necessary to allow it to known as retinoids, physiologically speaking, vitamin A is not enter the nucleus and bind with DNA. It is the action a retinoid because it does not interact directly with retinoid of retinoic acid on the DNA that accounts for all the receptors in our skin cells. Cells have to first convert vitamin A biological effects on the skin. to retinoic acid. Retinoic acid regulates the expression Retinoic acid facilitates communication between cells, of cellular genes via the activation of two encouraging ageing cells to continue their renewal process and classes of nuclear retinoid receptors, regenerate collagen and elastin. known as retinoic acid receptors (RARs) and retinoid X receptors (RXRs). Ultimately, these MEASURING RETINOL forms of retinoids carry out many physiological Vitamin preparations are advertised by the percent of vitamin processes, such as cell differentiation, maintenance they contain, but the body uses them in terms of international of cell turnover and certain immunity functions. units, or IU, which are measured in terms of biological activity. The major biological activities of retinol are One IU of vitamin A is equal to 0.3 micrograms of vitamin A. So, the control of epithelial cell proliferation 1 gram of vitamin A would equal 1 million micrograms/0.3 = 3.33 and differentiation, immune modulation, million units of vitamin A. stimulation of the creation of new blood To expand this one step further, 100g of a 1% vitamin A vessels, and production of collagen. Some solution contains 1 gram of vitamin A (or 1 million micrograms) or other functions include inhibition of carcinogenesis, 3.33 million units of vitamin A. absorption of UV light, antioxidant function and pigment > 46 Aesthetic Medicine • November 2016 SKIN/DERMATOLOGY www.aestheticmed.co.uk VITAMIN A Without question, the greatest boon to anti- ageing treatments was the introduction of retinoic acid by Albert M Kligman, MD, PhD in 1986. Since then, the world of vitamin A has exploded and many new compounds have been developed to treat a host of skin conditions Aesthetic Medicine • November 2016 47 SKIN/DERMATOLOGY VITAMIN A www.aestheticmed.co.uk control. In addition, since retinoids contain several conjugated double bonds, they can trap free radicals and thus protect DNA, lipid membranes and proteins from UV- induced oxidative stress. At this time, little is known about what regulates the uptake of retinoids by cells. RETINOIDS IN MORE DETAIL RETINOIC ACID Also known by its brand name Tretinoin, retinoid acid is a prescription only substrate of vitamin A. Typical strength of topical Tretinoin creams ranges from 0.025 to 0.1 percent. Side effects are not uncommon and include skin irritation, dryness, peeling and sun sensitivity. With Tretinoin, more is not necessarily better. Studies indicate that 0.025 percent Tretinoin may be almost as effective as 0.05 or 0.1 percent, but with a lower incidence of skin irritation. According to studies, improvement on Tretinoin may continue for up to a year of continued use.1 RETINAL/RETINALDEHYDE Retinaldehyde is easily converted to retinoic acid in the body in just one step. It could conceivably have the same effect effectiveness. Notably, retinyl retinoate is reported to be on acne as directly acting retinoids. Furthermore, since it is more resistant to inactivation by sunlight than retinol and less irritating than retinoids, retinaldehyde may be easier to most other forms of vitamin A. If true, this would make it an combine with other potentially irritating acne treatments, especially practicable choice for skin care formulations. such as alpha-hydroxy acids, beta-hydroxy acids or benzoyl However, vitamin A in all forms is destroyed by UV light— peroxide. In fact, two studies have demonstrated the both the UVB (290–320 nm) and UVA (320–400) spectra so effectiveness of topical 0.1% retinaldehyde combined with night time application is advised. 6% glycolic acid in treating acne. Also, there is evidence that In addition, a study by the National Toxicology Program, retinaldehyde possesses some antimicrobial activity against which is a U.S. government research group, has concluded P. acnes, the bacteria involved in the development of acne.2 that retinyl palmitate and retinoic acid speed the development of skin cancers and tumours when applied RETINYL RETINOATE to the skin in the present of sunlight (NTP 2012). This is yet Retinyl retinoate is a molecule that is produced by chemically another reason for applying retinoids in the evening and joining the molecules of retinoic acid and retinol in the body. washing your face in the morning. Just one metabolic step is required to split it back into retinoic acid and retinol, at which point retinoic acid is immediately CLINICAL APPLICATIONS OF VITAMIN A active, whereas retinol can be converted to additional Vitamin A can be used to treat several clinical conditions, retinoic acid later on. As a result, biological activity of retinyl including acne, ageing skin and hyperpigmentation. Each of retinoate in the skin is reportedly higher than that of retinol the forms of vitamin A—retinol, retinyl acetate and retinyl (and possibly even retinaldehyde) and may be approaching palmitate—has specific reasons why it would be selected for that of retinoic acid itself.3 a particular treatment or patient over the others. Microencapsulation of vitamin A is an effective way to RETINYL ESTERS ensure stability, delivery and efficacy of retinol. A synthetic Retinyl esters are the storage phase of retinol and serve no wax or polymer encases the vitamin A, protects it while on known biological activity other than to store vitamin A. In the shelf and slowly breaks down in the skin. This creates a foods of animal origin, the major form of vitamin A is an ester, time released delivery of retinol leading to less irritation. primarily retinyl palmitate, which is converted to retinol, Because vitamin A is drip fed into the skin in small doses, the which is chemically an alcohol (see pathway above). body can metabolise it over a longer period and more retinol is converted into retinoic acid. AM STABILITY OF VITAMIN A Even if a retinol or retinaldehyde product maintains its 1 - http://www.smartskincare.com/treatments/topical/retinaldehyde.html potency until it is actually used (due to good formulation 2 - http://www.smartskincare.com/treatments/topical/retinaldehyde.html and proper storage), it often gets inactivated by exposure 3 - http://www.smartskincare.com/treatments/topical/retinyl-retinoate.html to sunlight soon after application, which results in reduced Victoria Hiscock is the product and education specialist for Alumier Labs UK and has been educating skin >> care professionals for over a decade. Co-owner of CLINICBEAUTY, a medispa in Southampton, Victoria brings a vast spectrum of knowledge and education based on her hands on experience as well as her time as a trainer. She has a passion for Cosmetic Science and empowering fellow practitioners to develop their profitability through education. 48 Aesthetic Medicine • November 2016.
Recommended publications
  • Vitamin A: History, Current Uses, and Controversies M
    Vitamin A: History, Current Uses, and Controversies M. Shane Chapman, MD Vitamin A is required for the proper functioning of many important metabolic and physio- logic activities, including vision, gene transcription, the immune system and skin cell differentiation. Both excessive and deficient levels of vitamin A lead to poor functioning of many human systems. The biologically active form, retinoic acid, binds to nuclear receptors that facilitate transcription that ultimately leads to it’s physiological effects. Retinoids are derivatives of vitamin A that are medications used to treat acne vulgaris, psoriasis, ichthyosis (and other disorders of keratinization), skin cancer prevention as well as several bone marrow derived neoplasias. Systemic retinoids are teratogenic and have to be prescribed with caution and close oversight. Other potential adverse events are contro- versial. These include the relationship of retinoid derivatives in sunscreens, their effects on bone mineral density, depression and suicidal ideation and inflammatory bowel disease. These controversies will be discussed in detail. Semin Cutan Med Surg 31:11-16 © 2012 Published by Elsevier Inc. KEYWORDS vitamin A, retinoids, carotenoids, sunscreens, bone metabolism, teratogenicity, depression, suicidal ideation, istotretinoin, inflammatory bowel disease. itamin A is a fat-soluble vitamin that is required for the molecules, retinal, for both low-light- and color vision. Ret- Vproper functioning of a diverse array of metabolic and inol is also converted to retinoic acid, which is a hormone- physiologic activities. Vision, hematopoiesis, embryonic de- like growth factor important for epithelial cell growth and velopment, skin cell differentiation, immune system func- differentiation. It is required for skin and bone health, but in tion, and gene transcription all require vitamin A.
    [Show full text]
  • Effect of Cooking Loss in the Assessment of Vitamin Intake for Epidemiological Data in Japan
    European Journal of Clinical Nutrition (2011) 65, 546–552 & 2011 Macmillan Publishers Limited All rights reserved 0954-3007/11 www.nature.com/ejcn ORIGINAL ARTICLE Effect of cooking loss in the assessment of vitamin intake for epidemiological data in Japan M Kobayashi1,2, HY Adachi2, J Ishihara2,3 and S Tsugane2 for the JPHC FFQ Validation Study Group 1Department of Food Science, Faculty of Home Economics, Otsuma Women’s University, Tokyo, Japan; 2Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan and 3Department of Nutrition, Junior College of Tokyo University of Agriculture, Tokyo, Japan Background/Objectives: The effect of cooking loss on vitamin intake is an important consideration in dietary and epidemiological studies in Japanese. However, because few published food values have considered cooking effect, allowing for cooking loss in the assessment of vitamin intake in Japan has been difficult. Subjects/Methods: Seven-day dietary records and a fasting blood sample were collected from 102 men and 113 women in August of 1994 or 1995. Vitamin intake were estimated using two food databases, one composed of raw food only and the second of cooked food. Estimates were compared with blood levels. Results: Water-soluble vitamin intake using a food database including cooked food was lower than intakes estimated using a database composed of raw food only, except for pantothenic acid and vitamin B12 intake. In particular, vitamin B1 intake was 18.9% lower in men and 16.8% lower in women. However, when subjects were classified into the same and adjacent categories by joint classification by quintiles, appreciable change in ranking of a subject was not observed.
    [Show full text]
  • R Graphics Output
    Dexamethasone sodium phosphate ( 0.339 ) Melengestrol acetate ( 0.282 ) 17beta−Trenbolone ( 0.252 ) 17alpha−Estradiol ( 0.24 ) 17alpha−Hydroxyprogesterone ( 0.238 ) Triamcinolone ( 0.233 ) Zearalenone ( 0.216 ) CP−634384 ( 0.21 ) 17alpha−Ethinylestradiol ( 0.203 ) Raloxifene hydrochloride ( 0.203 ) Volinanserin ( 0.2 ) Tiratricol ( 0.197 ) trans−Retinoic acid ( 0.192 ) Chlorpromazine hydrochloride ( 0.191 ) PharmaGSID_47315 ( 0.185 ) Apigenin ( 0.183 ) Diethylstilbestrol ( 0.178 ) 4−Dodecylphenol ( 0.161 ) 2,2',6,6'−Tetrachlorobisphenol A ( 0.156 ) o,p'−DDD ( 0.155 ) Progesterone ( 0.152 ) 4−Hydroxytamoxifen ( 0.151 ) SSR150106 ( 0.149 ) Equilin ( 0.3 ) 3,5,3'−Triiodothyronine ( 0.256 ) 17−Methyltestosterone ( 0.242 ) 17beta−Estradiol ( 0.24 ) 5alpha−Dihydrotestosterone ( 0.235 ) Mifepristone ( 0.218 ) Norethindrone ( 0.214 ) Spironolactone ( 0.204 ) Farglitazar ( 0.203 ) Testosterone propionate ( 0.202 ) meso−Hexestrol ( 0.199 ) Mestranol ( 0.196 ) Estriol ( 0.191 ) 2,2',4,4'−Tetrahydroxybenzophenone ( 0.185 ) 3,3,5,5−Tetraiodothyroacetic acid ( 0.183 ) Norgestrel ( 0.181 ) Cyproterone acetate ( 0.164 ) GSK232420A ( 0.161 ) N−Dodecanoyl−N−methylglycine ( 0.155 ) Pentachloroanisole ( 0.154 ) HPTE ( 0.151 ) Biochanin A ( 0.15 ) Dehydroepiandrosterone ( 0.149 ) PharmaCode_333941 ( 0.148 ) Prednisone ( 0.146 ) Nordihydroguaiaretic acid ( 0.145 ) p,p'−DDD ( 0.144 ) Diphenhydramine hydrochloride ( 0.142 ) Forskolin ( 0.141 ) Perfluorooctanoic acid ( 0.14 ) Oleyl sarcosine ( 0.139 ) Cyclohexylphenylketone ( 0.138 ) Pirinixic acid ( 0.137 )
    [Show full text]
  • Pathway Development Via Retinoid X Receptor Vitamin a Enhances In
    Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway This information is current as Charles B. Stephensen, Reuven Rasooly, Xiaowen Jiang, of September 24, 2021. Michael A. Ceddia, Casey T. Weaver, Roshantha A. S. Chandraratna and R. Patterson Bucy J Immunol 2002; 168:4495-4503; ; doi: 10.4049/jimmunol.168.9.4495 http://www.jimmunol.org/content/168/9/4495 Downloaded from References This article cites 40 articles, 24 of which you can access for free at: http://www.jimmunol.org/content/168/9/4495.full#ref-list-1 http://www.jimmunol.org/ Why The JI? Submit online. • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication by guest on September 24, 2021 *average Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2002 by The American Association of Immunologists All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. Vitamin A Enhances in Vitro Th2 Development Via Retinoid X Receptor Pathway1 Charles B. Stephensen,2* Reuven Rasooly,* Xiaowen Jiang,* Michael A. Ceddia,3* Casey T. Weaver,† Roshantha A. S. Chandraratna,‡ and R. Patterson Bucy† Vitamin A deficiency diminishes Th2-mediated Ab responses, and high-level dietary vitamin A or treatment with the vitamin A metabolite retinoic acid (RA) enhances such responses.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2012/0202780 A1 Gavin Et Al
    US 20120202780A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2012/0202780 A1 Gavin et al. (43) Pub. Date: Aug. 9, 2012 (54) CARRIER COMPOSITION Publication Classification (76) Inventors: Paul David Gavin, Chadstone (51) Int. Cl. (AU); Mahmoud El-Tamimy, A6II 47/24 (2006.01) Meadow Heights (AU); Jeremy A6II 3/196 (2006.01) James Cottrell, Caulfield South A6IP5/00 (2006.01) (AU); Giacinto Gaetano, South A 6LX 3/573 (2006.01) Melbourne (AU); Nicholas John A6IP 23/00 (2006.01) Kennedy, Boronia (AU) A6IP 29/00 (2006.01) A6II 3/167 (2006.01) (21) Appl. No.: 13/501,494 A63L/407 (2006.01) (22) PCT Fled: Dec. 22, 2010 (52) U.S. Cl. ......... 514/180: 514/785: 514/788: 514/772: 514/626; 514/567; 514/413: 514/179 (86) PCT NO.: S371 (c)(1), (57) ABSTRACT (2), (4) Date: Apr. 12, 2012 A carrier composition of the present invention comprises a phosphate compound of an electron transfer agent and a rela Related U.S. Application Data tively high concentration of a polar protic solvent. A biologi (60) Provisional application No. 61/289,507, filed on Dec. cally active compound may be formulated with a carrier com 23, 2009. position of the present invention to provide a formulation. Patent Application Publication Aug. 9, 2012 Sheet 1 of 5 US 2012/0202780 A1 - - if solvent E. -ie-20% solvent 3. ". S. .t E FGURE 1 Patent Application Publication Aug. 9, 2012 Sheet 2 of 5 US 2012/0202780 A1 -H 10 LC2 s -C- 20 ulcm2 . - a 30 ulcm2 t E re FIGURE 2A HO licm2 80i -o- 20 ul/cm2 'i -A-30 ul/cm2 140 EO 10 8 8 4) O O FIGURE 2B Patent Application Publication Aug.
    [Show full text]
  • TAZORAC® (Tazarotene) Gel 0.05% (Tazarotene) Gel 0.1%
    NDA 020600 ® TAZORAC (tazarotene) Gel 0.05% (tazarotene) Gel 0.1% FOR DERMATOLOGIC USE ONLY NOT FOR OPHTHALMIC, ORAL, OR INTRAVAGINAL USE DESCRIPTION TAZORAC® Gel is a translucent, aqueous gel and contains the compound tazarotene, a member of the acetylenic class of retinoids. It is for topical dermatologic use only. The active ingredient is represented by the following structural formula: O OCH2CH3 N S TAZAROTENE C21H21NO2S Molecular Weight: 351.46 Chemical Name: Ethyl 6-[(4,4-dimethylthiochroman-6-yl)ethynyl]nicotinate Contains: Active: Tazarotene 0.05% or 0.1% (w/w) Preservative: Benzyl alcohol 1% (w/w) Inactives: Ascorbic acid, butylated hydroxyanisole, butylated hydroxytoluene, carbomer 934P, edetate disodium, hexylene glycol, poloxamer 407, polyethylene glycol 400, polysorbate 40, purified water, and tromethamine. CLINICAL PHARMACOLOGY Tazarotene is a retinoid prodrug which is converted to its active form, the cognate carboxylic acid of tazarotene (AGN 190299), by rapid deesterification in animals and man. AGN 190299 (“tazarotenic acid”) binds to all three members of the retinoic acid receptor (RAR) family: RARα, RARβ, and RARγ but shows relative selectivity for RARβ, and RARγ and may modify gene expression. The clinical significance of these findings is unknown. Psoriasis: The mechanism of tazarotene action in psoriasis is not defined. Topical tazarotene blocks induction of mouse epidermal ornithine decarboxylase (ODC) activity, which is associated with cell proliferation and hyperplasia. In cell culture and in vitro models of skin, tazarotene suppresses expression of MRP8, a marker of inflammation present in the epidermis of psoriasis patients at high levels. In human keratinocyte cultures, it inhibits cornified envelope formation, whose build-up is an element of the psoriatic scale.
    [Show full text]
  • Vitamins a and E and Carotenoids
    Fat-Soluble Vitamins & Micronutrients: Vitamins A and E and Carotenoids Vitamins A (retinol) and E (tocopherol) and the carotenoids are fat-soluble micronutrients that are found in many foods, including some vegetables, fruits, meats, and animal products. Fish-liver oils, liver, egg yolks, butter, and cream are known for their higher content of vitamin A. Nuts and seeds are particularly rich sources of vitamin E (Thomas 2006). At least 700 carotenoids—fat-soluble red and yellow pigments—are found in nature (Britton 2004). Americans consume 40–50 of these carotenoids, primarily in fruits and vegetables (Khachik 1992), and smaller amounts in poultry products, including egg yolks, and in seafoods (Boylston 2007). Six major carotenoids are found in human serum: alpha-carotene, beta-carotene, beta-cryptoxanthin, lutein, trans-lycopene, and zeaxanthin. Major carotene sources are orange-colored fruits and vegetables such as carrots, pumpkins, and mangos. Lutein and zeaxanthin are also found in dark green leafy vegetables, where any orange coloring is overshadowed by chlorophyll. Trans-Lycopene is obtained primarily from tomato and tomato products. For information on the carotenoid content of U.S. foods, see the 1998 carotenoid database created by the U.S. Department of Agriculture and the Nutrition Coordinating Center at the University of Minnesota (http://www.nal.usda.gov/fnic/foodcomp/Data/car98/car98.html). Vitamin A, found in foods that come from animal sources, is called preformed vitamin A. Some carotenoids found in colorful fruits and vegetables are called provitamin A; they are metabolized in the body to vitamin A. Among the carotenoids, beta-carotene, a retinol dimer, has the most significant provitamin A activity.
    [Show full text]
  • Oxidation of Retinol to Retinoic Acid As a Requirement for Biological Activity in Mouse Epidermis1
    [CANCER RESEARCH 48, 7038-7040, December 15, 1988] Oxidation of Retinol to Retinoic Acid as a Requirement for Biological Activity in Mouse Epidermis1 Michael J. Connor Division of Dermatology, Department of Medicine, UCLA School of Medicine, Los Angeles, California 90024 ABSTRACT of retinal, which may explain its ability to inhibit both steps in The food and fragrance additive citral (3,7-dimethyl-2,6-octadienal) retinoic acid synthesis from retinol, since as an aldehyde it can inhibits the oxidation of retino! to retinole acid in mouse epidermis on act as a substrate for both the alcohol- and aldehyde-dehydro- local application. This inhibitory property was used to test the hypothesis genases involved. that oxidation to retinole acid is rate limiting for the biological activity The ability of citral to inhibit retinol oxidation provides an of vitamin A (retinol) in epithelial tissues. Citral was tested as a modulator experimental tool for testing the paradigm that retinoic acid is of the biological activities of retinol and retinole acid using two bioassays an obligatory intermediate in at least some aspects of vitamin performed in Skh.hrI (hairless) mice: (a) the ability to induce epidermal A activity in the epithelia in vivo. Citral was proposed as a hyperplasia; (/>)the ability to inhibit the induction of epidermal ornithine vitamin A antagonist in 1956 (7). Aydelotte (8, 9) studied the decarboxylase activity by tumor promoters. Citral treatment inhibited interaction of citral and retinol in whole organ cultures of chick the ability of retinol, but not of retinoic acid, to induce epidermal epithelial tissues and concluded that citral had a competitive hyperplasia.
    [Show full text]
  • Manual for Sugar Fortification with Vitamin a Part 3
    Manual for Sugar Fortification with Vitamin A Part 3 Analytical Methods for the Control and Evaluation of Sugar Fortification with Vitamin A Omar Dary, Ph.D. Guillermo Arroyave, Ph.D. with Hernando Flores, Ph.D., Florisbela A. C. S. Campos, and Maria Helena C. B. Lins Dr. Omar Dary is a research biochemist at the Institute of Nutrition of Central America and Panama (INCAP), Guatemala. Dr. Guillermo Arroyave is an international consultant in micronutrients residing in San Diego, California. Dr. Hernando Flores, Ms. Campos, and Ms. Lins are biochemists at the Universidad de Pernambuco, Brazil. MANUAL FOR SUGAR FORTIFICATION PART 3 TABLE OF CONTENTS ACKNOWLEDGMENTS ........................................................... v FOREWORD ...................................................................vii I. INTRODUCTION .......................................................... 1 II. PROPERTIES OF RETINOL AND RETINOL COMPOUNDS USED IN SUGAR FORTIFICATION .......................................................... 3 III. PRINCIPLES FOR DETERMINING RETINOL IN VITAMIN A PREMIX AND FORTIFIED SUGAR .................................................................. 5 A. Spectrophotometric method ............................................. 5 B. Colorimetric method .................................................. 6 IV. SPECTROPHOTOMETRIC DETERMINATION OF RETINOL IN PREMIX ........... 7 A. References .......................................................... 7 B. Principle ............................................................ 7 C. Critical
    [Show full text]
  • Biological and Biochemical Studies on the Effect of Vitamin a And
    Australian Journal of Basic and Applied Sciences, 5(4): 102-110, 2011 ISSN 1991-8178 Effect of Vitamin A and Iodine Status on Thyroid Gland Functions in Rats Zakia Mostafa Abdel-kader, Heba Barakat, Rasha Hamed Mahmoud and Nehad Naem Shosha Department of Biochemistry and Nutrition, Women's College, Ain Shams University Abstract: Vitamin A (VA) deficiency (VAD) and iodine deficiency (ID) disorders (IDD) are major global public health problems, mostly affecting women of reproductive age and young children. The present study aims to investigate the effect of iodine and VA (deficient, sufficient or supplement) alone and in combination on of thyroid gland functions in hypothyroid rat model. 60 weaning male albino rats were fed on VA and iodine deficient diet for 4 weeks to induce hypothyroidism. Then they were divided into six groups, 10 rats per group. Each group received different diet which differs in their content of iodine and VA for a consecutive 2 weeks. These groups were compared with 20 control rats. Serum TSH, TT4, FT4, TT3, and FT3 were measured to estimate the efficiency of each diet on treatment of hypothyroidism. Also, serum retinol was measured to determine the influence of VA in replenishing VA deficiency status. Moreover, hepatic and serum lipid profiles, serum glucose, and hepatic glycogen were estimated to detect the effect of thyroid gland functions on cardiovascular disease and carbohydrate metabolism. The results showed that, however VA alone was effective in improvement TSH level; it had no effect on thyroid gland function. Whereas, when VA was in combination with iodine in the sufficient diet, they significantly promoted the normalization of thyroid gland functions than iodine alone.
    [Show full text]
  • Conversion Factors for Vitamin a and Carotenoids
    NEW! CONVERSION FACTORS FOR VITAMIN A AND CAROTENOIDS Vitamin A and carotenoids can be quanti- fied in several different units, but it is preferable to use the International System of Units (SI) such as µmol: SI Units Commonly Used Units 1µmol retinol (vitamin A) = 286 µg retinol (vitamin A) 1µmol β-carotene = 537 µg β-carotene Supplements, food, and animal feed: 0.00349 µmol retinol (vitamin A) = 1µg retinol (vitamin A) 1.15 µg retinyl acetate 1.83 µg retinyl palmitate 3.33 IU (1 IU = 0.3 µg) For example, vitamin A in an oil supplement: 209 µmol retinol (vitamin A) = 200,000 IU 60,000 µg retinol (vitamin A) Retinol concentrations in: Serum: 1 µmol/L = 28.6 µg/dL Liver: 1 µmol/g = 286 µg/g Milk: 1 µmol/L = 28.6 µg/dL Fat: 1 µmol/g = 286 µg/g Unit conversion for commonly used cutoff values for serum retinol (vitamin A) concentration: 0.35 µmol/L = 10 µg/dL 0.70 µmol/L = 20 µg/dL 1.05 µmol/L = 30 µg/dL INTERNATIONAL VITAMIN A CONSULTATIVE GROUP (IVACG) RETINOL ACTIVITY EQUIVALENT The term “retinol activity equivalent” (RAE) was introduced by the U.S. Institute of Medicine (IOM)1 to replace “retinol equivalent” (RE) used by FAO/ WHO2 to take into account new research on the vitamin A activity (bioefficacy) of carotenoids. The IOM deemed carotenoid bioefficacy in mixed foods eaten by healthy people in developed countries to be half the required amount set by FAO/WHO. Bioefficacy may, in fact, be even lower in popula- tions in developing countries.3 References: 1.
    [Show full text]
  • Risk Assessment of Vitamin a (Retinol and Retinyl Esters) in Cosmetics
    Risk assessment of vitamin A (retinol and retinyl esters) in cosmetics Opinion of the Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics of the Norwegian Scientific Committee for Food Safety Date: 22.08.12 Doc. no.: 10-405-3 final ISBN: 978-82-8259-059-4 Norwegian Scientific Committee for Food Safety (VKM) 10/405-3 final Risk assessment of vitamin A (retinol and retinyl esters) in cosmetics Ragna Bogen Hetland (Chair) Berit Granum Claus Lützow-Holm Jan Ludvig Lyche Jan Erik Paulsen Vibeke Thrane 2 Norwegian Scientific Committee for Food Safety (VKM) 10/405-3 final Contributors Persons working for VKM, either as appointed members of the Committee or as ad hoc experts, do this by virtue of their scientific expertise, not as representatives for their employers. The Civil Services Act instructions on legal competence apply for all work prepared by VKM. Acknowledgements The Norwegian Scientific Committee for Food Safety (Vitenskapskomiteen for mattrygghet, VKM) has appointed a working group consisting of both VKM members and external experts to answer the request from the Norwegian Food Safety Authority. The members of the working group are acknowledged for their valuable work on this opinion. The members of the working group are: VKM members Ragna Bogen Hetland, Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics (Chair) Berit Granum, Panel on Food Additives, Flavourings, Processing Aids, Materials in Contact with Food and Cosmetics Jan Ludvig
    [Show full text]